Drug Trial Radar · NCT07477990
Clinical Trial to Evaluate the Efficacy and Safety of the Aurora® Digital Medical Device in Adult Patients With Moderate to Severe Generalized Anxiety Disorder
Last checked: Nov 20, 2026Latest source record: Apr 1, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
162
Planned (sponsor's estimate)
Start
Mar 29, 2026
Primary completion
Jun 29, 2027
Study completion Jul 1, 2027
Sponsor
- Lead sponsor
- Psicofarma, S.A. De C.V.Industry
- Sponsor type
- Industry
- First posted
- Mar 17, 2026
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated drug
- No
- Who can join
- All sexes, from 18 years, up to 65 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
To evaluate the superiority of cognitive behavioral therapy using the Aurora® digital medical device + conventional drug treatment, compared to conventional drug treatment alone, in reducing anxiety symptoms, as assessed by the change in the GAD-7 scale at 12 weeks of treatment, relative to baseline.
Conditions
- General Anxiety Disorder
Interventions
App AURORA (Digital Therapy) + conventional treatmentOther
81 patients using Digital Therapy Aurora + conventional pharmacological treatment for 12 weeks
Pharmacological conventional treatmentDrug
81 patients using conventional pharmacological treatment for 12 weeks
Primary outcomes
What the sponsor says the trial is designed to measure.
- GAD-7 scaleTime frame: 12 weeks
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Servicios Especializados En Ensayos Clinicos, Seec, Sc
Mexico City, Mexico City, Mexico · Recruiting
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.